Table 3 Stem cell targeting nanodrugs for HER2-positive breast cancer
From: Nanotechnology approaches to addressing HER2-positive breast cancer
Nanotechnology | Stem cell target | Therapy | References |
|---|---|---|---|
Conjugation of hyaluronic acid and grafting the doublecortin-like kinase 1 monoclonal antibody to the surface of nanoparticles | CD44 receptors | None | Qiao et al. (2016) |
Encapsulated polymeric nanoparticle surface modified with chitosan | CD44 receptors | Doxorubicin | Rao et al. (2015) |
Fluorescent micelles | CD44 and EGRF | Paclitaxel | Gener et al. (2015) |